KWD 2019

Modify Date: 2024-01-09 17:31:07

KWD 2019 Structure
KWD 2019 structure
Common Name KWD 2019
CAS Number 23031-25-6 Molecular Weight 225.28400
Density 1.171 g/cm3 Boiling Point 419.2ºC at 760 mmHg
Molecular Formula C12H19NO3 Melting Point 204-208ºC
MSDS N/A Flash Point 165.3ºC

 Use of KWD 2019


Terbutaline is a short-acting agonist of β2-adrenergic receptor (β2-AR) . Terbutaline is an active metabolite of bambuterol and used as a bronchodilator and to prevent premature labor[1][2].

 Names

Name terbutaline
Synonym More Synonyms

 KWD 2019 Biological Activity

Description Terbutaline is a short-acting agonist of β2-adrenergic receptor (β2-AR) . Terbutaline is an active metabolite of bambuterol and used as a bronchodilator and to prevent premature labor[1][2].
Related Catalog
Target

Beta-2 adrenergic receptor

References

[1]. Hoffmann C, et al. Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol. 2004 Feb;369(2):151-9.

[2]. Gaudet LM, et al. Effectiveness of terbutaline pump for the prevention of preterm birth. A systematic review and meta-analysis. PLoS One. 2012;7(2):e31679.

 Chemical & Physical Properties

Density 1.171 g/cm3
Boiling Point 419.2ºC at 760 mmHg
Melting Point 204-208ºC
Molecular Formula C12H19NO3
Molecular Weight 225.28400
Flash Point 165.3ºC
Exact Mass 225.13600
PSA 72.72000
LogP 1.91020
Vapour Pressure 3.42E-07mmHg at 25°C
Index of Refraction 1.4596 (estimate)

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DN8960000
CHEMICAL NAME :
Benzyl alcohol, alpha-((t-butylamino)methyl)-3,5-dihydroxy-
CAS REGISTRY NUMBER :
23031-25-6
LAST UPDATED :
199612
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C12-H19-N-O3
MOLECULAR WEIGHT :
225.32
WISWESSER LINE NOTATION :
QR CQ EYQ1MX1&1&1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Multiple routes
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
380 ug/kg
TOXIC EFFECTS :
Cardiac - other changes
REFERENCE :
JAMAAP JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- Volume(issue)/page/year: 244,692,1980
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
714 ug/kg
TOXIC EFFECTS :
Behavioral - tremor Cardiac - arrhythmias (including changes in conduction) Cardiac - change in rate
REFERENCE :
NEJMAG New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- Volume(issue)/page/year: 300,143,1979 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Multiple routes
DOSE :
5660 ug/kg
SEX/DURATION :
female 32-34 week(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - Apgar score (human only) Reproductive - Effects on Newborn - biochemical and metabolic
REFERENCE :
JOPDAB Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- Volume(issue)/page/year: 94,449,1979
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
6 mg/kg
SEX/DURATION :
female 17-19 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - respiratory system Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
REFERENCE :
PEREBL Pediatric Research. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1967- Volume(issue)/page/year: 25,617,1989
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
30 mg/kg
SEX/DURATION :
female 17-19 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - Central Nervous System
REFERENCE :
BRBUDU Brain Research Bulletin. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1976- Volume(issue)/page/year: 23,263,1989
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
30 mg/kg
SEX/DURATION :
female 17-19 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - endocrine system
REFERENCE :
RCOCB8 Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- Volume(issue)/page/year: 76,269,1992
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
62500 ng/kg
SEX/DURATION :
female 16-20 day(s) after conception
TOXIC EFFECTS :
Reproductive - Maternal Effects - other effects
REFERENCE :
BMMBES Biochemical Medicine and Metabolic Biology. (Academic Press, Inc., Journal Customer Service, POB 6250, Duluth, MN 55802-0250) V.35- 1986- Volume(issue)/page/year: 52,128,1994 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X4191 No. of Facilities: 58 (estimated) No. of Industries: 1 No. of Occupations: 2 No. of Employees: 1405 (estimated) No. of Female Employees: 941 (estimated)

 Safety Information

RIDADR UN 3077 9
HS Code 2942000000

 Customs

HS Code 2922509090
Summary 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

 Synonyms

1-(3,5-dihydroxyphenyl)-2-(tert-butylamino)-ethanol
TelMisartan API
SNGP-003-04H08
MICARDIS
[3H]-Telmisartan
4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
BIBR 277
BIBR 277SE
4'-[(2-n-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)-methyl]-2-carboxy-biphenyl
5-(1-Hydroxy-2-tert-butylamino-ethyl)benzene-1,3-diol
TIMISHATAN
Telmisaran
5-[2-(tertbutylamino)-1-hydroxyethyl]benzene-1,3-diol
PRITOR
4'-[[2-n-propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)-benzimidazol-1-yl]methyl]-biphenyl-2-carboxylic acid
[3H]-Terbutaline
EINECS 245-385-8
TU-199
TIMETAZIDINE
Top Suppliers:I want be here



Get all suppliers and price by the below link:

KWD 2019 suppliers

KWD 2019 price